drugset
drugset / Trial / NCT01579734

Phase III, Randomized, Double Blind Trial Low Dose Tamoxifen Versus Placebo in Hormone Replacement Therapy (HRT) Users

NCT01579734 ↗

Phase 3 Unknown 1884 enrolled European Institute of Oncology
RandomizedParallel-groupTriple-blindPrevention

Summary

The propose of this trial is to assess the effect of low dose tamoxifen for breast cancer prevention in HRT (Hormone Replacement Therapy)users.

Timeline

Start
2002-03
Primary completion
2018-12
Completion
2023-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tamoxifen Small molecule 5 mg —

Indications

breast cancer